Condensed Statements of Cash Flows (USD $)	9 Months Ended		95 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Operating Activities:
Net loss	$ (19,999,353)	$ (17,814,827)	$ (231,774,687)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,659,940	4,664,985	29,173,087
Stock based compensation	538,365	761,351	13,350,057
Common stock issued for services	104,000	0	162,950
Realized loss on forward contracts	0	0	1,430,766
Foreign currency transaction loss (gain)	0	5,365	(590,433)
Amortization of financing costs and discounts	0	0	998,565
Impairment loss	0	0	83,171,090
Contract cancellation loss	0	0	1,167,586
Change in fair value of make-whole dividend liability	(70,272)	0	(70,272)
Changes in operating assets and liabilities:
Accounts receivable	5,150	240,597	(95,014)
Related party receivables and deposits	586,114	(631,825)	(10,225)
Inventories	62,055	101,602	(2,097,498)
Prepaid expenses and other current assets	(524,400)	(115,326)	(759,705)
Accounts payable	(247,802)	(186,372)	607,570
Accrued expenses	(102,069)	136,553	735,529
Warranty reserve	9,750	10,918	47,937
Net cash used in operating activities	(14,978,522)	(12,826,979)	(104,552,697)
Investing Activities:
Purchases of available-for-sale-securities	0	(638,572)	(907,118,828)
Maturities and sales of available-for-sale securities	0	13,253,650	907,118,828
Purchase of property, plant and equipment	(497,373)	(5,363,111)	(135,319,376)
Restricted cash for manufacturing equipment	0	1,427,053	0
Patent activity costs	(359,702)	(73,657)	(883,773)
Net cash provided by (used in) investing activities	(857,075)	8,605,363	(136,203,149)
Financing Activities:
Proceeds from bridge loan financing	0	0	1,600,000
Repayment of bridge loan financing	0	0	(1,600,000)
Payment of debt financing costs	0	0	(273,565)
Payment of equity offering costs	0	0	(10,302,040)
Proceeds from debt	0	0	7,700,000
Repayment of debt	(197,057)	(584,506)	(2,381,987)
Proceeds from shareholder under Section 16(b)	0	0	148,109
Proceeds from issuance of stock and warrants	7,291,467	12,080,536	249,793,747
Redemption of Class A warrants	0	0	(48,128)
Net cash provided by (used in) financing activities	7,094,410	11,496,030	244,636,136
Net change in cash and cash equivalents	(8,741,187)	7,274,414	3,880,290
Cash and cash equivalents at beginning of period	12,621,477	12,621,477	0
Cash and cash equivalents at end of period	3,880,290	3,880,290	3,880,290
Non-Cash Transactions:
ITN initial contribution of assets for equity	0	0	31,200
Note with ITN and related capital expenditures	0	0	1,100,000
Make-whole provision on convertible preferred stock	1,783,017	0	1,783,017
Beneficial conversion feature on convertible preferred stock	$ 2,421,062	$ 0	$ 2,421,062